4Suppliers
6Customers
1Debt Items
20Related Chains

Source-Backed Evidence Depth

Renalytix plc (RENXF) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

11Total relationships
1Distinct source URLs
1High confidence
0.736Average confidence
2026-10-05Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Renalytix plc Suppliers

TickerNameConfidenceEvidence
ABT Abbott Laboratories 72% Medicare and other healthcare funding and otherwise affect the price of KidneyIntelX and any diagnostic product for which we may obtain regulatory approval or the frequency with which any such produc…
ABT Abbott Laboratories 72% Reciprocal relationship from ABT graph: Reciprocal relationship from RENXF graph: Reciprocal relationship from ABT graph: Reciprocal relationship from RENXF graph: Medicare and other healthcare fundi…
BIO Bio-Rad Laboratories, Inc. 72% Medicare and other healthcare funding and otherwise affect the price of KidneyIntelX and any diagnostic product for which we may obtain regulatory approval or the frequency with which any such produc…
BIO Bio-Rad Laboratories, Inc. 72% Reciprocal relationship from BIO graph: Reciprocal relationship from RENXF graph: Medicare and other healthcare funding and otherwise affect the price of KidneyIntelX and any diagnostic product for w…

Renalytix plc Customers

TickerNameConfidenceEvidence
ABT Abbott Laboratories 72% Medicare and other healthcare funding and otherwise affect the price of KidneyIntelX and any diagnostic product for which we may obtain regulatory approval or the frequency with which any such produc…
ABT Abbott Laboratories 72% Reciprocal relationship from ABT graph: Reciprocal relationship from RENXF graph: Medicare and other healthcare funding and otherwise affect the price of KidneyIntelX and any diagnostic product for w…
BIO Bio-Rad Laboratories, Inc. 72% Medicare and other healthcare funding and otherwise affect the price of KidneyIntelX and any diagnostic product for which we may obtain regulatory approval or the frequency with which any such produc…
BIO Bio-Rad Laboratories, Inc. 72% Reciprocal relationship from BIO graph: Reciprocal relationship from RENXF graph: Reciprocal relationship from BIO graph: Reciprocal relationship from RENXF graph: Medicare and other healthcare fundi…
TECH Bio-Techne Corporation 72% t the aggregate outstanding $ million convertible loan notes into ordinary shares of VericiDx. As a result of the VericiDx IPO, the Company deconsolidated VericiDx from the consolidated financial sta…
TECH Bio-Techne Corporation 72% Reciprocal relationship from TECH graph: Reciprocal relationship from RENXF graph: Reciprocal relationship from TECH graph: Reciprocal relationship from RENXF graph: t the aggregate outstanding $ mil…

Renalytix plc Debt Obligations

InstrumentDescriptionConfidenceEvidence
RENXF-DEBT-12131 Xbrl Convertible 90% xbrl convertible detail from xbrl 2024-09-30.

Renalytix plc Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Renalytix plc.

Renalytix plc Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Renalytix plc.

Renalytix plc Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ABT Abbott Laboratories 100.00 1 ['customer', 'supplier']
TECH Bio-Techne Corporation 100.00 1 ['customer']
BIO Bio-Rad Laboratories, Inc. 100.00 1 ['customer', 'supplier']
GRAL GRAIL, Inc. 50.00 2
BBNX Beta Bionics, Inc. 50.00 2
GCTK GlucoTrack, Inc. 50.00 2
DYN Dyne Therapeutics, Inc. 50.00 2
HAE Haemonetics Corporation 50.00 2
EXAS Exact Sciences Corp 50.00 2
CODX Co-Diagnostics, Inc. 50.00 2
GIKLY Grifols, S.A. 50.00 2
GRFS Grifols, S.A. 50.00 2
DXCM DexCom, Inc. 50.00 2
FLGT Fulgent Genetics, Inc. 50.00 2
ONCO Onconetix, Inc. 50.00 2
PSNL Personalis, Inc. 50.00 2
HBIO Harvard Bioscience, Inc. 50.00 2
ENTA Enanta Pharmaceuticals, Inc. 50.00 2
ALVO Alvotech 50.00 2
AORT Artivion, Inc. 50.00 2
🔐
RENXF
Unlock RENXF Supply Chain Data
Verified relationships include:
ABTAbbott LaboratoriesSupplier72%
ABTAbbott LaboratoriesSupplier72%
ABTAbbott LaboratoriesCustomer72%
ABTAbbott LaboratoriesCustomer72%
+7 more relationships locked
Subscribe — View plans →